AbCellera Biologics Inc.
USD8.12
+0.74 (+10.03%)
CEO
Carl Hansen
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$7.56
Prev. Close
$7.38
Day Low
$7.39
Day High
$8.42
52W Low
$2.75
52W High
$8.42
Market Cap
$2.48B
Volume
14.27M
| 111,701 |
| $5.27 |
| 12 Jun 2026 | Montalbano John S. | director | A-Award | Acquired | 111,701 | $5.27 |
| 11 Jun 2026 | Sandor Victor | director: | Disposed | 0 | $0.00 |
| 18 May 2026 | Montalbano John S. | director | P-Purchase | Acquired | 20,000 | $4.77 |
| 2 Mar 2026 | Thermopylae Holdings Ltd. | 10 percent owner | P-Purchase | Acquired | 38,000 | $3.44 |
| 27 Feb 2026 | Thermopylae Holdings Ltd. | 10 percent owner | P-Purchase | Acquired | 177,457 | $3.27 |
| 27 Feb 2026 | Booth Andrew | Chief Financial Officer | P-Purchase | Acquired | 42,600 | $3.42 |
| 5 Jan 2026 | Booth Andrew | Chief Financial Officer | A-Award | Acquired | 808,898 | $3.42 |
| 5 Jan 2026 | Hansen Carl L. G. | director, 10 percent owner, officer: Chief Executive Officer | A-Award | Acquired | 2,106,505 | $3.42 |